MITO - Stealth Bio announces non-binding buyout offer
The clinical-stage biotech Stealth BioTherapeutics (NASDAQ:MITO) announced on Monday that the company received a preliminary non-binding proposal to buy its shares for cash in a going-private transaction for $0.026 per share and US$0.313 per ADS. Morningside Venture (I) Investments Ltd and J. Wood Capital Advisors LLC issued the proposal letter dated June 24, 2022, Stealth Bio (MITO) added. A special committee the company appointed to evaluate the strategic alternatives now expects to obtain the services of a financial advisor to evaluate the proposal or any other alternative transactions. Stealth Bio (MITO) has not yet taken a final decision on the buyout offer or any other transaction it intends to pursue. Stealth Bio (MITO) shares are currently on hold for trading.
For further details see:
Stealth Bio announces non-binding buyout offer